Project Grant R03DK147806
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Miriam Hospital a Project Grant of $111,750 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 5, 2026, with completion targeted for April 30, 2028. This R03 Small Grant supports the refinement and testing of an evidence-based healthcare provider training program designed specifically for clinicians treating adolescents and young...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $151,448 to the University of California, Davis on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop and pilot test a patient-centered virtual intervention addressing the critical healthcare transition period for adolescents and young adults (AYAs) with Type 1 Diabetes (T1D). The research applies...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $232,875 Project Grant effective September 5, 2025, through June 30, 2027, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This mixed-methods research initiative will characterize clinician communication practices around glycemic management in primary care diabetes consultations and identify the most...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Tufts University School of Medicine a Project Grant of $838,493 on April 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research is being conducted in Dallas, Texas, with a completion date of February 28, 2031. The project, titled "Optimizing Interventions to Improve Nutrition Security and Reduce Diabetes Risk Among...
- Federal Grant Award Summary The University of Florida received a $153,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, through April 30, 2028. The award supports research investigating thymic output in the context of genetics, environmental exposures, and progression to type 1 diabetes (T1D). The research addresses...
- Federal Grant Award Summary Children's Hospital Los Angeles received a $141,087 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 30, 2025 through April 30, 2027. The award supports basic biomedical research investigating the role of the NGN3 protein in Notch signaling repression during pancreatic endocrinogenesis, with direct...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $1.45 million Project Grant to Beckman Research Institute of the City of Hope, effective August 20, 2025, through June 30, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award funds fundamental and translational research investigating chromatin remodeling factors and mechanisms in diabetic microvascular complications. The...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Children's Hospital of Philadelphia Research Institute a $343,278 Project Grant effective July 16, 2025, through March 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a multi-omic investigation of uremic toxin sources and accumulation in children with kidney failure, addressing the high morbidity and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Virginia a $1.44 million Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for the period May 1, 2026 through April 30, 2029. This ancillary research project will utilize data and peripheral blood mononuclear cell (PBMC) samples from the Environmental Determinants of Diabetes in the Young (TEDDY) longitudinal...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Nemours Foundation $114,000 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on May 12, 2026, with a completion date of April 30, 2028. This Project Grant funds the development of provider-focused dissemination strategies for evidence-based psychosocial care in Type 1 Diabetes (T1D) treatment. The research team will conduct a community-engaged study guided by the Designing for Dissemination (D4D) framework to gather perspectives from T1D healthcare providers—including endocrinologists and other practitioners—through survey methodologies and collaborative research partnerships. The primary deliverable is a set of tailored dissemination strategies designed to increase T1D provider awareness and utilization of evidence-based psychosocial interventions for youth with Type 1 Diabetes. By centering the viewpoints of healthcare providers who serve as trusted sources of information for families, the research aims to bridge the implementation-to-practice gap and improve health outcomes for pediatric T1D patients. The project leverages existing partnerships with T1D provider networks and incorporates expertise from dissemination science, mixed-methods research, and behavioral health specialists, with support from Nemours Biomedical Research in Wilmington, Delaware.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $114.0k | 5/13/26 |